dtx
Also, AI cancer treatment software provider PVMed scores $14M in Series A funding.
It features a 24-session guided game that is paired with an EEG headband to track brainwaves.
It claims to help people stop smoking in four weeks.
Also, CureApp is getting $77 million in investment from the Sawai Group as part of their license deal.
The new funds will be used to support the rollout of its hypertension DTx app.
The app has been recommended as an effective alternative to sleeping pills in the UK.
The clearance represents what could be the world's first regulatory approval of a DTx app for hypertension treatment.
They plan to infuse AI, big data, and cloud technologies with digital therapeutics.
Experts share their predictions for the year ahead.
The digital therapeutic company purchased assets from Waypoint Health Innovations and from Örebro University researcher Fredrik Holländare.